BIOSYNERGY INC Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2022-01-21: Form 8-K; Period of report 2022-01-18; Description 2.01 Completion of Acquisition or Disposition of Assets; 8.01 Other Events; Details 2.01.
- 2022-01-05: Form 8-K; Period of report 2021-12-28; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
- 2021-11-30: Form 8-K; Period of report 2021-11-23; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
- 2021-07-08: Form 8-K; Period of report 2021-07-02; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2022-01-21 | 8-K | 2022-01-18 | 2.01 Completion of Acquisition or Disposition of Assets; 8.01 Other Events | 2.01 On November 24, 2021, Biosynergy, Inc. (“Biosynergy” or the “Company”) filed a Current Report on Form 8-K disclosing that the Company entered into an Asset Purchase Agreement (the “Agreement”) on November 23, 2021 with LCR Hallcrest, LLC (“Hallcrest”) for the sale of substantially all of the Company’s assets to Hallcrest (the “Asset Sale”) (which included a copy of the Agreement as an Exhibit to the Form 8-K). 8.01 On January 20, 2022, the Company issued a press release announcing the closing of the Asset Sale. | bsyn20220121_8k.htm |
| 2022-01-05 | 8-K | 2021-12-28 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | bsyn20220104_8k.htm |
| 2021-11-30 | 8-K | 2021-11-23 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | bsyn20211124_8k.htm |
| 2021-07-08 | 8-K | 2021-07-02 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On July 8, 2021, Biosynergy, Inc. (“Biosynergy”) announced that Laurence C. Mead, Chief Operating Officer, Chief Financial Officer, Chief Accounting Officer and Treasurer, resigned from Biosynergy effective July 2, 2021. | tm2121766d1_8k.htm |
| 2021-06-04 | 8-K | 2021-05-31 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On June 4, 2021, Biosynergy, Inc. (“Biosynergy”) announced that Laurence C. Mead resigned from his position on the Board of Directors effective May 31, 2021. | tm2118841d1_8k.htm |
| 2018-05-31 | 8-K | 2018-05-29 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | bsyn8k18.htm | |
| 2017-07-12 | 8-K | 2017-04-30 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | bsyn8k17.htm | |
| 2013-01-08 | 8-K | 2013-01-08 | 9.01 Financial Statements and Exhibits | bsyn8k13.htm | |
| 2009-08-28 | 8-K | 2009-08-27 | 9.01 Financial Statements and Exhibits | bio8k09.txt | |
| 2009-07-02 | 8-K | 2009-06-30 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | bio8k.txt | |
| 2006-11-15 | 8-K | 2006-11-11 | 9.01 Financial Statements and Exhibits | bio8k11.txt | |
| 2006-06-30 | 8-K | 2006-06-29 | 9.01 Financial Statements and Exhibits | bio8kj06.txt | |
| 2004-12-14 | 8-K | 2004-12-10 | 1.01 Entry into a Material Definitive Agreement | bio8kn04.txt |